comparemela.com

Latest Breaking News On - Iopharmaceutical - Page 1 : comparemela.com

China s CAR T market comes of age

Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, product development, clinical trials and more

Wuxi apptec coPharmaceuticals incJuno therapeutics incLegend biotech corpJuventas cell therapy ltdNanjing legend biotech corpJuno therapeuticsWuxi apptecJuventas cell therapyMedical deviceMedical technology

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.

Eli lilly zepboundRezdiffra resmetiromMadrigal rezdiffraZealand pharmaBristol myers squibb pegbelferminNovo nordisk ozempicAlison labyaRibocure pharmaceuticalsGlobal partnership deal valueGlobal partnership deals boehringer ingelheimDrug administrationDatabase of globaldata pharma intelligence centerEncouragement for the pharmaceutical companiesNovo nordiskNordisk initiates groundbreaking collaborationsInnovative obesity

A look at drug development in Alzheimer s disease

Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation, business, financing, regulation, science, product development, clinical trials and more

Howard fillitAuguste deterAlzheimer drug discovery foundationBiogen incNational academiesDrug discovery foundationMedical deviceMedical technology

Ocugen to Host Conference Call on Tuesday, April 2 at 8:30

MALVERN, Pa., April 01, 2024 (GLOBE NEWSWIRE) Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering,.

Exchange commissionHead of communicationsOcugen incPrivate securities litigation reform actNasdaq ocgnGene therapy

PRISM MarketView Highlights Work of Emerging Companies on

PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day.

Neurocrine biosciencesCancer prevention pharmaceuticals incRare disease dayPriority reviewBiologics license applicationPrescription drug user fee actPrevention pharmaceuticalsDuchenne muscular dystrophyRegenerative medicine advanced therapyDiazoxide cholinePrism marketviewStock indexRare disease dayPrism marketview

vimarsana © 2020. All Rights Reserved.